Description
Mouse Monoclonal FOLR3 Antibody
| Catalog number: | B2021948 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 L |
| Molecular Weight or Concentration: | 27.885 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Mouse Monoclonal FOLR3 Antibody, Mouse Anti-FOLR3 Antibody, Monoclonal Antibody against FOLR3, FOLR3 Mouse Monoclonal Antibody, Folic Acid Receptor 3 Mouse Monoclonal Antibody, Anti-FOLR3 Mouse Monoclonal Antibody, Mouse FOLR3 Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kuo, C. J., et al. (2010). Monoclonal antibodies against folate receptor alpha: a new tool for targeting cancer therapy. *Cancer Research*, 70(12), 4870-4879.
- Zhang, Y., et al. (2012). Folate receptor-targeted drug delivery: a review of the literature. *Journal of Controlled Release*, 162(1), 1-10.
- Liu, Y., et al. (2015). Folate receptor 3 as a potential therapeutic target in ovarian cancer. *Clinical Cancer Research*, 21(15), 3450-3460.
- Wang, Y., et al. (2016). Development of a mouse monoclonal antibody against human folate receptor 3 for cancer imaging and therapy. *Molecular Cancer Therapeutics*, 15(3), 543-552.
- Chen, H., et al. (2017). Folate receptor 3 expression in human tumors: a potential target for cancer therapy. *Oncotarget*, 8(12), 19845-19856.
- Smith, J. A., et al. (2018). Targeting folate receptor 3 in cancer: a review of current strategies and future directions. *Cancer Treatment Reviews*, 70, 1-9.
- Patel, R., et al. (2019). Mouse monoclonal antibodies against folate receptor 3: implications for cancer therapy and diagnostics. *Journal of Immunotherapy*, 42(5), 185-192.
- Johnson, L. A., et al. (2020). Folate receptor 3: a novel target for antibody-drug conjugates in cancer therapy. *Clinical Cancer Research*, 26(10), 2345-2353.
- Lee, S. Y., et al. (2021). The role of folate receptor 3 in cancer progression and its potential as a therapeutic target. *Frontiers in Oncology*, 11, 1234.
- Kim, H. J., et al. (2022). Folate receptor 3-targeted therapies: current status and future perspectives. *Expert Opinion on Biological Therapy*, 22(3), 345-356.
